Abstract:Abstract Background Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated with reduced life expectancy. It is heritable and an extensive repertoire of genetic variants have been identified. The gut microbiota may represent an environmental risk factor for RA. Indeed, Prevotella copri is a candidate keystone species, but whether it lies on the causal pathway for disease or is simply a bystander reflecting host-genetic predisposition to RA, remains to be determined. The study of disease-microbiota associations may be confounded by the presence of the disease of interest or by its treatment. To circumvent this issue, we assessed whether known RA risk alleles were associated with the gut microbiota, in a large who do not have RA. Methods Blood and stool acquired from volunteers from TwinsUK were used for genotyping and assessment of the gut microbiota, respectively. A weighted polygenic risk score (PRS) for RA was calculated in 1650 unaffected twins from the TwinsUK cohort, based on 233 published GWAS-identified published RA associated single nucleotide polymorphisms (SNPs). Amplicon sequence variants (ASVs) were generated from 16S rRNA sequencing of stool samples and assessed for association with RA PRS. Confirmation of findings was performed using an independent sample comprised of first-degree relatives of RA patients from the SCREEN-RA cohort (n=133). Findings We found that Prevotella spp was positively associated with RA PRS in TwinsUK participants (p.adj<1e-7). This finding was validated in SCREEN-RA participants carrying the shared epitope risk alleles (p.adj=1.12e-3). An association of Prevotella spp . with pre-clinical RA phases was also demonstrated (p.adj=0.021). Interpretation Prevotella in the gut microbiota is associated with RA genotype in the absence of RA, as well as in subjects at high risk of developing RA. This work suggests that host genotype is associated with microbiota profile prior to disease onset. Research in context Evidence before this study? Prevotella copri is increased within the gut microbiota in rheumatoid arthritis (RA) patients, predominantly those with early disease, before treatment is initiated. Prevotellaceae (family) has been demonstrated to be increased in pre-clinical RA cases compared to controls. Prevotella copri is posited to be an inflammatory driver, contributing to RA pathology by promoting a pro-inflammatory cytokine milieu. What does this study add? This study is the first to demonstrate that, in a large human cohort, carrying genetic risk factors for RA is associated with a higher abundance of Prevotella spp . in the absence of RA. How might this impact on clinical practice or future developments This work suggests that any potential causal role of Prevotella spp . occurs very early in disease development. Strategies to intervene should target early or asymptomatic at-risk groups

Prevotella copri in individuals at risk for rheumatoid arthritis

A polygenic risk score for rheumatoid arthritis sheds light on the Prevotella association

Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis

Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis

Periodontitis in First Degree-Relatives of Individuals With Rheumatoid Arthritis: A Short Narrative Review

A High-Fiber Diet Synergizes with Prevotella Copri and Exacerbates Rheumatoid Arthritis

Treatment response in rheumatoid arthritis is predicted by the microbiome: a large observational study in UK DMARD-naive patients

The role of the microbiome in rheumatoid arthritis: a review

Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis

Arthritis susceptibility and the gut microbiome

The curious case of Prevotella copri

Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study

Multidimensional profile of gut microbiota in a large cohort of stratified rheumatoid arthritis

Targeting Probiotics in Rheumatoid Arthritis

Alterations of gut fungal microbiota in patients with rheumatoid arthritis

Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China

The role of microbiota on rheumatoid arthritis onset

Alterations of the intestinal microbiome and metabolome in women with rheumatoid arthritis

Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression

The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis

A Shifted Composition and Dysbiosis of Urinary Microbiota in Rheumatoid Arthritis: A Case-Control Study